These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8211464)

  • 1. Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions.
    Robson SC; Pillans P; Willcox PA
    S Afr Med J; 1993 Jun; 83(6):432-4. PubMed ID: 8211464
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic complications of antituberculosis therapy revisited.
    Cohen CD; Sayed AR; Kirsch RE
    S Afr Med J; 1983 Jun; 63(25):960-3. PubMed ID: 6857425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver injury under tuberculostatic treatment].
    Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
    Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide].
    Musch E; Loos U; Schwabe HK
    Pneumologie; 1990 Feb; 44 Suppl 1():486-7. PubMed ID: 2367444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.
    Vu D; Macdonald L
    CMAJ; 2001 Oct; 165(7):942-3, 946-7. PubMed ID: 11599338
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
    Yew WW; Lee J; Wong PC; Kwan SY
    Int J Clin Pharmacol Res; 1992; 12(4):173-8. PubMed ID: 1297640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
    Farrell FJ; Keeffe EB; Man KM; Imperial JC; Esquivel CO
    Dig Dis Sci; 1994 Oct; 39(10):2255-9. PubMed ID: 7924752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis therapy.
    Lefrock JL; Smith BR
    Am Fam Physician; 1983 Mar; 27(3):261-4. PubMed ID: 6829397
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
    Neill P; Pringle D; Mhonda M; Kusema T; Nhachi CF
    Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculous patients in a U.S. Public Health Service Cooperative Therapy Trial.
    Cross FS; Long MW; Banner AS; Snider DE
    Am Rev Respir Dis; 1980 Aug; 122(2):349-53. PubMed ID: 6998337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoniazid is not always the cause of hepatitis during treatment of tuberculosis.
    van der Kooi K; Mottet JJ; Regamey C
    Clin Infect Dis; 1994 Nov; 19(5):987-8. PubMed ID: 7893906
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 15. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory disturbance related to pyrazinamide.
    Tsou CC; Chien JY
    QJM; 2014 Mar; 107(3):217-8. PubMed ID: 24023071
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
    Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
    Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis induced by combined rifomycin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.